Latest Financial Health News

Xstate Resources has disposed of its 20% stake in the Austrian Anshof project, eliminating liabilities and streamlining its portfolio ahead of a planned ASX re-listing and development of its Diona project in Queensland.

Challenger Gold Limited has voluntarily suspended its ASX trading pending a significant capital raising announcement, signaling potential strategic moves ahead.

BetMakers Technology Group reports solid Q3 FY25 financial gains alongside a strategic binding agreement to acquire Nevada’s LVDC, expanding its global racing technology footprint.

Kore Potash is advancing negotiations on a critical financing term sheet with the Summit Consortium for its Congo potash projects, signaling a pivotal step toward project development.

Tasmea Limited has declared a fully franked special dividend of 12 cents per share, reflecting robust financial performance and strong confidence in future growth prospects.

Pepper Money Limited has announced a fully franked special dividend of 12.5 cents per share, reflecting its robust cash position and ongoing capital management strategy. The payout totals approximately $55.5 million, with key dates set for June and July 2025.

Resimac Group Limited has announced a fully franked special dividend of 12 cents per share following a strategic review and sale of non-core assets, signalling disciplined capital management and shareholder value focus.

Opthea Limited faces a pivotal moment as four board members resign following disappointing Phase 3 trial results and a major workforce reduction. The company’s future hinges on ongoing funding negotiations amid trading suspensions.

Toys"R"Us ANZ Limited reported a significant increase in product margins and sales revenue despite inventory challenges, while advancing a recapitalisation plan to secure its financial future.

QEM Limited's trading suspension has been lifted immediately following its announcement of a new capital raise, signaling a pivotal moment for the company’s financial strategy.

Aroa Biosurgery has reported FY25 results that exceed revenue guidance and deliver a positive normalised EBITDA, setting the stage for ambitious growth and reimbursement expansion in FY26.

RPMGlobal Holdings has announced a 12-month extension to its on-market share buy-back program, adding up to 11 million shares to be repurchased. This move underscores the company’s confidence in its valuation and capital management strategy.